Media Centre

Text with Title

Evaluate's commercial intelligence on the pharmaceutical, biotechnology, and medical device industries is consistently referenced by leading business and industry publications such as the Financial Times, Wall Street Journal, and Nature.

Download our latest Media Kit for a forward-looking view of top companies, products, and more to support your editorial content.

Media Kit

To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us.

Jennifer Dinkel, Evaluate
Media & general questions
     

Latest Media Coverage

FierceBiotech

Biotech's top 10 money raisers of 2018

That hefty average made up for a 10% dip in the number of financing rounds, from 442 to 393, the lowest in a decade, according to a Vantage analysis. The megarounds that…

The Pharma Letter

Look back at pharma news in the week to May 10

Lundbeck has made no secret of its desire for acquisitions, and last week it delivered a takeout of Abide Therapeutics for an initial $250 million, noted Amy Brown on…

Vantage logo
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.